This website uses cookies for functional and analytical purposes. Please click 'accept' to to keep browsing.

  • Our platform
  • Careers
  • About
  • News
  • Contact
Contacts
  • San Francisco, US
  • T: +4686111212
  • E: info@enginzyme.com
  • Stockholm, Sweden
  • T: +46-8-6111212
  • E: info@enginzyme.com

News

Stay up to date with our latest news

Explore
decoration

Latest press releases

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology...

Oct 25, 2023

EnginZyme News

Five questions on pseudouridine, with Matthew Thompson

Press releases are necessarily short, so we like to go...

Oct 25, 2023

More news

All Article Blog Pressrelease

How we hire rockstars who play well together

Feb 16, 2023

Blog

EnginZyme Selected for the Second Year in a Row for Cleantech Group’s Global Cleantech 100 List of Companies Committed to Taking Action on the Climate Crisis

Jan 12, 2023

Blog

Announcing our Series B round

Dec 19, 2022

Blog

EnginZyme Raises €21 Million in Series B to Accelerate the Commercialisation of Its Cell-Free Biomanufacturing Technology

Dec 19, 2022

Pressrelease

World-leading chemicals manufacturer Eternis starts collaboration with EnginZyme

Nov 07, 2022

Blog

Testing catalysts in flow – the EnginZyme approach

Jul 12, 2022

Blog

1 2 3 4 … 7

Media contact

image description

Karim Engelmark Cassimjee

CEO and co-founder
  • press@enginzyme.com

Media kit

  • Download images
  • Download presskit

Stay in touch with us.
Sign up here for EnginZyme Insights.

Thanks for signing up!

Please check your email inbox to confirm.

Could not submit form.

Please check for errors.

© 2014 – 2025 EnginZyme AB

About
  • About EnginZyme
  • Careers
  • Contact us
Products and services
  • Our platform
Contact
  • E: info@enginzyme.com
  • Tomtebodavägen 6
  • 171 65 Solna, Sweden